Click Here to return To Results

 

Randomized Controlled Trial of IVIg in Untreated Chronic Inflammatory Demyelinating Polyradiculoneuropathy Neurol 56:445-449, Mendell,J.R.,et al, 2001 See this aricle in Pubmed Article Abstract IVIg improves strength in patients with untreated CIDP by day 10 with continued benefit through day 42; more than one third improve by at least a functional grade on a disability scale. This study provides data supporting IVIg as the initia l treatment for FIDP.

Related Tags

(click to filter results - removes previous filter) gammaglobulin therapy,intravenous neuropathy,peripheral,treatment polyneuropathy,chronic inflammatory demyelinating treatment of neurologic disorder

Click Here to return To Results